Equities

ImmuPharma PLC

IMM:LSE

ImmuPharma PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)6.38
  • Today's Change-0.13 / -2.00%
  • Shares traded2.21m
  • 1 Year change63.59%
  • Beta6.5672
Data delayed at least 20 minutes, as of Feb 06 2026 16:35 GMT.
More ▼
DateOpenHighLowCloseVolume
Friday, February 06, 2026Fri, Feb 06, 20266.806.805.866.382,214,4722.21m
Thursday, February 05, 2026Thu, Feb 05, 20266.366.886.206.512,454,0132.45m
Wednesday, February 04, 2026Wed, Feb 04, 20266.727.206.126.363,328,9223.33m
Tuesday, February 03, 2026Tue, Feb 03, 20266.907.186.306.601,870,4051.87m
Monday, February 02, 2026Mon, Feb 02, 20266.246.906.026.612,343,2922.34m
Friday, January 30, 2026Fri, Jan 30, 20266.667.386.226.364,073,2714.07m
Thursday, January 29, 2026Thu, Jan 29, 20266.527.386.526.801,456,9051.46m
Wednesday, January 28, 2026Wed, Jan 28, 20266.727.366.546.911,342,6811.34m
Tuesday, January 27, 2026Tue, Jan 27, 20266.727.386.706.961,594,9211.59m
Monday, January 26, 2026Mon, Jan 26, 20266.567.366.527.042,867,9442.87m
Friday, January 23, 2026Fri, Jan 23, 20266.807.286.506.66835,990835.99k
Thursday, January 22, 2026Thu, Jan 22, 20266.527.266.407.001,413,4601.41m
Wednesday, January 21, 2026Wed, Jan 21, 20267.267.266.406.702,470,5862.47m
Tuesday, January 20, 2026Tue, Jan 20, 20266.627.386.606.901,406,9551.41m
Monday, January 19, 2026Mon, Jan 19, 20266.727.306.526.75886,264886.26k
Friday, January 16, 2026Fri, Jan 16, 20266.907.486.706.702,024,3462.02m
Thursday, January 15, 2026Thu, Jan 15, 20267.447.466.827.141,768,8281.77m
Wednesday, January 14, 2026Wed, Jan 14, 20267.107.346.557.164,161,8644.16m
Tuesday, January 13, 2026Tue, Jan 13, 20267.007.486.726.912,244,8632.24m
Monday, January 12, 2026Mon, Jan 12, 20267.507.686.726.866,841,8896.84m
Friday, January 09, 2026Fri, Jan 09, 20267.607.687.007.304,419,8424.42m
Thursday, January 08, 2026Thu, Jan 08, 20267.988.187.147.186,999,4147.00m
Data delayed at least 20 minutes, as of Feb 06 2026 16:35 GMT.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.